Abstract:OBJECTIVE:To investigate the activation pattern of signal transducers and activators of transcription (STAT) induced by vascular endothelial growth factor (VEGF) in CD34+ hematopoietic progenitor cells, and gain an insight into the molecular mechanism and signal transduction pathway of VEGF that has an effect on CD34+ hematopoietic progenitor cells.METHODS:After isolated from umbilical cord blood by using a high-gradient magnetically activated cell sorting system (MACS), CD34+ cells were stimulated by VEGF (50 ng/ml) for different time (0, 15, 30, 45, 60, 90 min) to detect the tyrosine phosphorylation and nuclear translocation of STAT-3 and STAT-5 with Western blot and immunocytochemistry methods. The expression of VEGF receptor-2 (VEGFR2) on the membrane of CD34+ progenitor cells was examined by immunocytochemistry. ATWLPPR, an effective peptide screened from phage epitope library by affinity for membrane-expressed VEGFR2 and blocking the binding of VEGF to VEGFR2, was used to determine whether the activation of STAT pathway induced by VEGF was blocked.RESULTS:Tyrosine phosphorylation of STAT-3 and STAT-5 was undetectable in unstimulated CD34+ cells, but was evident at 15 min in response to VEGF stimulation. VEGF resulted in a rapid and transient tyrosine phosphorylation of STAT-3 and STAT-5. The maximal tyrosine phosphorylation was catched at 30 and 45 min, respectively (P = 0.0001), and returned to basal levels at 90 min. Immunocytochemistry confirmed that increased phosphorylated STAT-3 was translocated into the nuclei at 30 min (P = 0.0001), and mainly in cytoplasms again at 90 min after stimulation with VEGF. However, compared with unstimulated CD34+ cells, there was only increased phosphorylation of STAT-5 appeared mainly in cytoplasms, but no significant nuclear translocation was found after stimulation with VEGF (P > 0.05). The presence of VEGFR2 was confirmed using anti-VEGFR2 antibody staining by immunocytochemistry, moreover, the phosphorylation of STAT-3 and STAT-5 failed to be activated by the co-culture with ATWLPPR and VEGF, suggesting that activation of the STAT pathway be specifically mediated by VEGFR2 in CD34+ progenitor cells.CONCLUSIONS:STAT signaling pathway participates in the signal transduction of VEGF via VEGFR2 in CD34+ hemopoietic progenitor cells.

The study of IGF-1 in stimulating expression of vascular endothelial growth factor-C in the breast cancer cell line MDA-MB-231

Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.

[Expression of Vascular Endothelial Growth Factor and Its Receptors in Laryngeal Carcinoma Cell and Its Significance].

In Vitro Study of HIF-1 Activation and VEGF Release by Bfgf in the T47D Breast Cancer Cell Line under Normoxic Conditions: Involvement of PI-3K/Akt and MEK1/ERK Pathways

[Expressions of VEGF/VEGFRs and Activation of STATs in Ovarian Carcinoma].

[Phosphorylation of Signal Transducer and Activators of Transcription 3 Induced by Vascular Endothelial Growth Factor in Ovarian Carcinoma Cell Line in Vitro].

[Activation of Signal Transducers and Activators of Transcription Induced by Vascular Endothelial Growth Factor in CD34+ Hematopoietic Progenitor Cells in Vitro].

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

Vegf Induces Phosphorylation of Stat3 Through Binding Vegfr2 in Ovarian Carcinoma Cells in Vitro

Biological Effects of Connective Tissue Growth Factor Transfection on Human Breast Cancer Cells

Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1.

Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells.

The Time and Concentration-Dependent Effects of Insulin-Related Microenviromental Factors on the Activation of MPAK/ERK Signaling Pathway in Endometrial Carcinoma Cells

The Influence of KCC1 Gene in Regulation of IGF-I to Proliferation Ability in Endometrial Cancer HEC-1B Cell

Interaction Between Igf-Ir And Er Induced By E2 And Igf-I

Insulin-like Growth Factor-I (IGF-I) Induces Epidermal Growth Factor Receptor Transactivation and Cell Proliferation Through Reactive Oxygen Species.

Expression of Human Vascular Endothelial Growth Factor in Cultured NIH3T3 Cells

Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets

Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803.

Basic FGF augments hypoxia induced HIF-1-alpha expression and VEGF release in T47D breast cancer cells.

EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3 IN HUMAN BREAST CANCER AND ITS SIGNIFICANCE